Connectivity Changes in Parkinson’s Disease

Current Neurology and Neuroscience Reports

Volumn 16, Issue 10, 2016, Pages

  Cerasa, Antonio ^a   Novellino, Fabiana ^a   Quattrone, Aldo ^a,b  

^a CNR   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Functional magnetic resonance imaging; Machine learning; Parkinson s disease; Resting state functional connectivity; Seed based approach

Indexed keywords

LEVODOPA;

BOLD SIGNAL; BRAIN DEPTH STIMULATION; DEFAULT MODE NETWORK; FREEZING OF GATE; FRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; HUMAN; MACHINE LEARNING; MOTOR NEURON DISEASE; NERVOUS SYSTEM PARAMETERS; NEUROIMAGING; PARKINSON DISEASE; RESTING STATE NETWORK; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATE CORTEX; SUBTHALAMIC NUCLEUS; SUPPLEMENTARY MOTOR AREA; CONNECTOME; DIAGNOSTIC IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES;

CONNECTOME; HUMANS; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE;

EID: 84984636508     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-016-0687-9     Document Type: Review

References (71)

1. Hassler R. Zur pathologie der paralysis agitans und des postenzephalitischen parkinsonismus. J Psychol Neurol. 1938;48:387–476.
2. Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9:13–24.
3. Langston JW. The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann Neurol. 2006;59:591–6.
4. Smith Y, Wichmann T, Factor SA, DeLong MR. Parkinson’s disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology. 2012;37:213–46.
5. Sulzer D, Surmeier DJ. Neuronal vulnerability, pathogenesis, and Parkinson’s disease. Mov Disord. 2013;28:41–50.
6. Stoessl AJ, Lehericy S, Strafella AP. Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia. Lancet. 2014;384:532–44.
7. Prodoehl J, Burciu RG, Vaillancourt DE. Resting state functional magnetic resonance imaging in Parkinson’s disease. Curr Neurol Neurosci Rep. 2014;14:448.
8. Stoessl AJ, Martin WRW, McKeown MJ, Sossi V. Advances in imaging in Parkinson’s disease. Lancet Neurol. 2011;10:987–1001.
9. Tuite PJ, Mangia S, Michaeli S. Magnetic resonance imaging (MRI) in Parkinson’s disease. J Alzheimer’s Dis Park. 2013;Suppl 1:1.
10. Pyatigorskaya N, Gallea C, Garcia-Lorenzo D, Vidailhet M, Lehericy S. A review of the use of magnetic resonance imaging in Parkinson’s disease. Ther Adv Neurol Disord. 2013;7:206–20.
11. Castellanos FX, Di Martino A, Craddock RC, Mehta AD, Milham MP. Clinical applications of the functional connectome. Neuroimage. 2013;80:527–40.
12. Zuo XN, Xing XX. Test-retest reliabilities of resting-state FMRI measurements in human brain functional connectomics: a systems neuroscience perspective. Neurosci Biobehav Rev Elsevier Ltd. 2014;45:100–18.
13. Raichle ME. Neuroscience. The brain’s dark energy. Science. 2006;314:1249–50.
14. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci. 2006;29:449–76.
15. Pinter D, Beckmann C, Koini M, Pirker E, Filippini N, Pichler A, et al. Reproducibility of resting state connectivity in patients with stable multiple sclerosis. PLoS One. 2016;11:e0152158.
16. Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, et al. Disease tracking markers for Alzheimer’s disease at the prodromal (MCI) stage. J Alzheimers Dis. 2011;26 Suppl 3:159–99.
17. Tahmasian M, Bettray LM, van Eimeren T, Drzezga A, Timmermann L, Eickhoff CR, et al. A systematic review on the applications of resting-state fMRI in Parkinson’s disease: does dopamine replacement therapy play a role? Cortex. 2015;73:80–105.
18. Borgwardt S, Fusar-Poli P. Third-generation neuroimaging in early schizophrenia: translating research evidence into clinical utility. Br J Psychiatry. 2012;200:270–2.
19. Weingarten CP, Sundman MH, Hickey P, Chen N. Neuroimaging of Parkinson’s disease: expanding views. Neurosci Biobehav Rev. 2015;59:16–52.
20. Bishop CM. Pattern recognition and machine learning. In: Jordan M, Kleinberg J, Scholkopf B, editors. Springer; 2006.
21. Noirhomme Q, Brecheisen R, Lesenfants D, Antonopoulos G, Laureys S. “Look at my classifier’s result”: disentangling unresponsive from (minimally) conscious patients. Neuroimage. 2015. doi:10.1016/j.neuroimage.2015.12.006.
22. Wang S, Summers RM. Machine learning and radiology. Med Image Anal. 2012;16:933–51.
23. Orrù G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. 2012;36:1140–52.
24. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368–76.
25. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8:700–11.
26. Buckner RL, Krienen FM, Castellanos A, Diaz JC, Yeo BT. The organization of the human cerebellum estimated by intrinsic functional connectivity. J Neurophysiol. p. 2322–45.
27. Raichle ME. The restless brain. Brain Connect. 2011;1:3–12.
28. Van Dijk KRA, Hedden T, Venkataraman A, Evans KC, Lazar SW, Buckner RL. Intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J Neurophysiol. 2010;103:297–321.
29. Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med. 1995;34:537–41.
30. Ouchi Y, Kikuchi M. A review of the default mode network in aging and dementia based on molecular imaging. Rev Neurosci. 2012;23:263–8.
31. van den Heuvel MP, Hulshoff Pol HE. Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol. 2010;20:519–34.
32. Hacker CD, Perlmutter JS, Criswell SR, Ances BM, Snyder AZ. Resting state functional connectivity of the striatum in Parkinson’s disease. Brain. 2012;135:3699–711.
33. Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I. Spatial remapping of cortico-striatal connectivity in Parkinson’s disease. Cereb Cortex. 2010;20:1175–86.
34. Yu R, Liu B, Wang L, Chen J, Liu X. Enhanced functional connectivity between putamen and supplementary motor area in Parkinson’s disease patients. PLoS One. 2013;8:e59717.
35. Baudrexel S, Witte T, Seifried C, von Wegner F, Beissner F, Klein JC, et al. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson’s disease. Neuroimage. 2011;55:1728–38.
36. Kurani AS, Seidler RD, Burciu RG, Comella CL, Corcos DM, Okun MS, et al. Subthalamic nucleus-sensorimotor cortex functional connectivity in de novo and moderate Parkinson’s disease. Neurobiol Aging. 2015;36:462–9.
37. Sharman M, Valabregue R, Perlbarg V, Marrakchi-Kacem L, Vidailhet M, Benali H, et al. Parkinson’s disease patients show reduced cortical-subcortical sensorimotor connectivity. Mov Disord. 2013;28:447–54.
38. Wu T, Long X, Wang L, Hallett M, Zang Y, Li K, et al. Functional connectivity of cortical motor areas in the resting state in Parkinson’s disease. Hum Brain Mapp. 2011;32:1443–57.
39. Helmich RC, Janssen MJR, Oyen WJG, Bloem BR, Toni I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol. 2011;69:269–81. In this study, Helmich and colleagues provide a complete neurophysiological and neurobiological picture of pathophysiological mechanisms underlying resting tremor in Parkinson’s disease (PD). They investigate functional connectivity between basal ganglia nuclei and cerebellothalamic circuit using resting-state fMRI, the severity of tremor using electromyographic evaluation, and striatal dopamine depletion with PET imaging. They found that (a) the activity in the cerebellum-thalamo-motor cortex network cofluctuated with tremor amplitude in PD patients, (b) pallidal dopamine depletion correlated with clinical tremor severity, and (c) in tremor-dominant PD, the most-affected pallidum showed increased functional connectivity with the motor cortex node.
40. Fling BW, Cohen RG, Mancini M, Carpenter SD, Fair DA, Nutt JG, et al. Functional reorganization of the locomotor network in Parkinson patients with freezing of gait. PLoS One. 2014;9:e100291.
41. Tessitore A, Amboni M, Esposito F, Russo A, Picillo M, Marcuccio L, et al. Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait. Parkinsonism Relat Disord. 2012;18:781–7. Authors investigated 16 Parkinson’s disease (PD) patients with freezing of gait (FOG), 13 PD without FOG, and 15 controls. They found that disruption of connectivity within the executive-attention and visual networks may be associated with the development of FOG.
42. Jenner P. Functional models of Parkinson’s disease: a valuable tool in the development of novel therapies. Ann Neurol. 2008;64:16–29.
43. Müller-Oehring EM, Sullivan EV, Pfefferbaum A, Huang NC, Poston KL, Bronte-Stewart HM, et al. Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s disease. Brain Imaging Behav. 2015;9:619–38.
44. Olde Dubbelink KTE, Schoonheim MM, Deijen JB, Twisk JWR, Barkhof F, Berendse HW. Functional connectivity and cognitive decline over 3 years in Parkinson disease. Neurology. 2014;83:2046–53. This is one of the few neuroimaging studies aimed at measuring the clinical disease progression of Parkinson’s disease (PD) patients. They investigated 36 PD patients in a 3-year follow-up period. In the baseline, PD patients are characterized by widespread changes in several brain networks with respect to controls. After 3 years, decreasing in functional connectivity progressively worsens, and it was associated with clinical deterioration, especially with cognitive decline. In particular, the posterior parts of the brain (i.e., precuneus, parietal cortex) showed reduction of functional connectivity. This follow-up study confirms that resting-state functional connectivity is an important hallmark of PD-related cognitive decline.
45. Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson’s disease: a review. J Neuropsychol. 2013;7:193–224.
46. Rektorova I, Krajcovicova L, Marecek R, Mikl M. Default mode network and extrastriate visual resting state network in patients with Parkinson’s disease dementia. Neurodegener Dis. 2012;10:232–7.
47. Vandekerckhove M, Panksepp J. A neurocognitive theory of higher mental emergence: from anoetic affective experiences to noetic knowledge and autonoetic awareness. Neurosci Biobehav Rev. 2011;35:2017–25.
48. Tessitore A, Esposito F, Vitale C, Santangelo G, Amboni M, Russo A, et al. Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology. 2012;79:2226–32.
49. Amboni M, Tessitore A, Esposito F, Santangelo G, Picillo M, Vitale C, et al. Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease. J Neurol. 2014;262:425–34.
50. Disbrow EA, Carmichael O, He J, Lanni KE, Dressler EM, Zhang L, et al. Resting state functional connectivity is associated with cognitive dysfunction in non-demented people with Parkinson’s disease. J Parkinson’s Dis. 2014;4:453–65.
51. Krajcovicova L, Mikl M, Marecek R, Rektorova I. The default mode network integrity in patients with Parkinson’s disease is levodopa equivalent dose-dependent. J Neural Transm. 2012;119:443–54.
52. Cerasa A, Gioia MC, Salsone M, Donzuso G, Chiriaco C, Realmuto S, et al. Neurofunctional correlates of attention rehabilitation in Parkinson’s disease: an explorative study. Neurol Sci. 2014;35:1173–80. In this neuroimaging study, we demonstrated that the activity of resting-state functional connectivity might be used as hallmark for evaluating the effectiveness of cognitive rehabilitation (CR). Using a randomized controlled study, a group of Parkinson’s disease (PD) patients underwent CR program tailored for attention abilities, while others PD underwent a placebo intervention. CR had beneficial effects on executive functions, which was sustained by underlying improved activity in the attention and central executive neural networks.
53. Luo C, Guo X, Song W, Chen Q, Yang J, Gong Q, Shang HF. The trajectory of disturbed resting-state cerebral function in Parkinson's disease at different Hoehn and Yahr stages. Hum Brain Mapp. 2015;36:3104–16.
54. Luo C, Chen Q, Song W, Chen K, Guo X, Yang J, et al. Resting-state fMRI study on drug-naive patients with Parkinson’s disease and with depression. J Neurol Neurosurg Psychiatry. 2014;4:675–83.
55. Sheng K, Fang W, Su M, Li R, Zou D, Han Y, et al. Altered spontaneous brain activity in patients with Parkinson’s disease accompanied by depressive symptoms, as revealed by regional homogeneity and functional connectivity in the prefrontal-limbic system. PLoS One. 2014;9:e84705.
56. Shine JM, Halliday GM, Gilat M, Matar E, Bolitho SJ, Carlos M, et al. The role of dysfunctional attentional control networks in visual misperceptions in Parkinson’s disease. Hum Brain Mapp. 2014;35:2206–19.
57. Yao N, Shek-Kwan Chang R, Cheung C, Pang S, Lau KK, Suckling J, et al. The default mode network is disrupted in Parkinson’s disease with visual hallucinations. Hum Brain Mapp. 2014;35:5658–66.
58. Ellmore TM, Castriotta RJ, Hendley KL, Aalbers BM, Furr-Stimming E, Hood AJ, et al. Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder. Sleep. 2013;36:1885–92.
59. Wu T, Long X, Zang Y, Wang L, Hallett M, Li K, et al. Regional homogeneity changes in patients with parkinson’s disease. Hum Brain Mapp. 2009;30:1502–10.
60. Kwak Y, Peltier SJ, Bohnen NI, Müller MLTM, Dayalu P, Seidler RD. L-DOPA changes spontaneous low-frequency BOLD signal oscillations in Parkinson’s disease: a resting state fMRI study. Front Syst Neurosci. 2012;6:52.
61. Esposito F, Tessitore A, Giordano A, De Micco R, Paccone A, Conforti R, et al. Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson’s disease by levodopa. Brain. 2013;136:710–25.
62. Cerasa A, Koch G, Donzuso G, Mangone G, Morelli M, Brusa L, et al. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. Brain. 2015;138:414–27.
63. Aron AR, Robbins TW, Poldrack RA. Inhibition and the right inferior frontal cortex: one decade on. Trends Cogn Sci. 2014;18:177–85.
64. Kahan J, Urner M, Moran R, Flandin G, Marreiros A, Mancini L, et al. Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on “effective” connectivity. Brain. 2014;137:1130–44.
65. Cerasa A. Machine learning on Parkinson’s disease? Let’s translate into clinical practice. J Neurosci Methods. 2016;266:161–2.
66. Cherubini A, Nisticó R, Novellino F, Salsone M, Nigro S, Donzuso G, et al. Magnetic resonance support vector machine discriminates essential tremor with rest tremor from tremor-dominant Parkinson disease. Mov Disord. 2014;29:1216–9.
67. Herz DM, Haagensen BN, Nielsen SH, Madsen KH, Løkkegaard A, Siebner HR. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson’s disease. Mov Disord. 2016;31:521–9. The Siebner’s group demonstrated that resting-state activity might be used for diagnostic and prognostic purposes. Indeed, using machine-learning algorithm, they automatically classified PD patients with and without levodopa-induced dyskinesias (LID) only using information from resting-state fMRI sequence. In particular, the altered connectivity between the putamen with the sensorimotor cortex allowed to perform the best discrimination (specificity 100%; sensitivity 91%) between PD with and without LID. Whereas, modulation of resting-state connectivity between the supplementary motor area and putamen predicted interindividual differences in dyskinesia severity.
68. Long D, Wang J, Xuan M, Gu Q, Xu X, Kong D, et al. Automatic classification of early Parkinson’s disease with multi-modal MR imaging. PLoS One. 2012;7:1–9.
69. Chen Y, Yang W, Long J, Zhang Y, Feng J, Li Y, et al. Discriminative analysis of Parkinson’s disease based on whole-brain functional connectivity. PLoS One. 2015;10:1–16.
70. Zhang D, Liu X, Chen J, Liu B. Distinguishing patients with Parkinson’s disease subtypes from normal controls based on functional network regional efficiencies. PLoS One. 2014;9:e115131.
71. Wu T, Ma Y, Zheng Z, Peng S, Wu X, Eidelberg D, et al. Parkinson’s disease-related spatial covariance pattern identified with resting-state functional MRI. J Cereb Blood Flow Metab. 2015;1:1–7.